nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—ADRB2—dilated cardiomyopathy	0.745	1	CbGaD
Phenoxybenzamine—CALM1—sympathetic nervous system—dilated cardiomyopathy	0.00451	0.241	CbGeAlD
Phenoxybenzamine—Bepridil—TNNC1—dilated cardiomyopathy	0.00321	0.465	CrCbGaD
Phenoxybenzamine—Propafenone—SCN5A—dilated cardiomyopathy	0.00161	0.234	CrCbGaD
Phenoxybenzamine—CALM3—cardiac ventricle—dilated cardiomyopathy	0.00123	0.066	CbGeAlD
Phenoxybenzamine—CALM3—myocardium—dilated cardiomyopathy	0.00116	0.0621	CbGeAlD
Phenoxybenzamine—CALM2—cardiac ventricle—dilated cardiomyopathy	0.000968	0.0518	CbGeAlD
Phenoxybenzamine—CALM1—cardiac ventricle—dilated cardiomyopathy	0.000963	0.0516	CbGeAlD
Phenoxybenzamine—CALM2—myocardium—dilated cardiomyopathy	0.00091	0.0488	CbGeAlD
Phenoxybenzamine—CALM1—myocardium—dilated cardiomyopathy	0.000906	0.0485	CbGeAlD
Phenoxybenzamine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.000889	0.129	CrCbGaD
Phenoxybenzamine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.000865	0.0463	CbGeAlD
Phenoxybenzamine—ADRA2C—myocardium—dilated cardiomyopathy	0.000814	0.0436	CbGeAlD
Phenoxybenzamine—CALM3—heart—dilated cardiomyopathy	0.000809	0.0433	CbGeAlD
Phenoxybenzamine—CALM3—cardiac atrium—dilated cardiomyopathy	0.000692	0.0371	CbGeAlD
Phenoxybenzamine—Propafenone—ADRB1—dilated cardiomyopathy	0.000642	0.0932	CrCbGaD
Phenoxybenzamine—CALM2—heart—dilated cardiomyopathy	0.000635	0.034	CbGeAlD
Phenoxybenzamine—CALM1—heart—dilated cardiomyopathy	0.000632	0.0339	CbGeAlD
Phenoxybenzamine—ADRA1A—heart—dilated cardiomyopathy	0.000596	0.0319	CbGeAlD
Phenoxybenzamine—ADRA2C—heart—dilated cardiomyopathy	0.000568	0.0304	CbGeAlD
Phenoxybenzamine—CALM2—cardiac atrium—dilated cardiomyopathy	0.000543	0.0291	CbGeAlD
Phenoxybenzamine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000541	0.0786	CrCbGaD
Phenoxybenzamine—CALM1—cardiac atrium—dilated cardiomyopathy	0.000541	0.029	CbGeAlD
Phenoxybenzamine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000486	0.026	CbGeAlD
Phenoxybenzamine—ADRA2A—heart—dilated cardiomyopathy	0.000453	0.0243	CbGeAlD
Phenoxybenzamine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000388	0.0208	CbGeAlD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD36—dilated cardiomyopathy	3.05e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD36—dilated cardiomyopathy	3.05e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.04e-05	0.000132	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.04e-05	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	3.02e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	3e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—RAC1—dilated cardiomyopathy	2.99e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—RAC1—dilated cardiomyopathy	2.99e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.97e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.97e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—RAC1—dilated cardiomyopathy	2.97e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.97e-05	0.000129	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.96e-05	0.000129	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	2.95e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.94e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.94e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.94e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.93e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.89e-05	0.000126	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.89e-05	0.000126	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—RAC1—dilated cardiomyopathy	2.88e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—RAC1—dilated cardiomyopathy	2.88e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.85e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.81e-05	0.000123	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.8e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.79e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.78e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.78e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.76e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.76e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.74e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.73e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.73e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.73e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.73e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.72e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.69e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.68e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.68e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.66e-05	0.000116	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.64e-05	0.000115	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.62e-05	0.000114	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.61e-05	0.000114	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.59e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.59e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.58e-05	0.000112	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.56e-05	0.000112	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.55e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.54e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.54e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.54e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.54e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.53e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.5e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.5e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	2.5e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—EGFR—dilated cardiomyopathy	2.47e-05	0.000108	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.46e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.46e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.46e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.45e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.43e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.43e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.4e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—EGFR—dilated cardiomyopathy	2.39e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—EGFR—dilated cardiomyopathy	2.39e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.38e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.33e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.32e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.29e-05	9.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—RAF1—dilated cardiomyopathy	2.28e-05	9.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.28e-05	9.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.26e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.26e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.26e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.26e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ITGB1—dilated cardiomyopathy	2.24e-05	9.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.24e-05	9.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.24e-05	9.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.22e-05	9.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—RAF1—dilated cardiomyopathy	2.21e-05	9.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—RAF1—dilated cardiomyopathy	2.21e-05	9.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.19e-05	9.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ITGB1—dilated cardiomyopathy	2.17e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ITGB1—dilated cardiomyopathy	2.17e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.17e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.16e-05	9.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.14e-05	9.3e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	2.11e-05	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.1e-05	9.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.1e-05	9.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.09e-05	9.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.07e-05	9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.06e-05	8.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.06e-05	8.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.06e-05	8.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—RAF1—dilated cardiomyopathy	2.05e-05	8.94e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	2.05e-05	8.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	2.05e-05	8.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.03e-05	8.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.03e-05	8.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	2e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.99e-05	8.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.99e-05	8.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.99e-05	8.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.99e-05	8.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.99e-05	8.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—RAF1—dilated cardiomyopathy	1.99e-05	8.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—RAF1—dilated cardiomyopathy	1.99e-05	8.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.97e-05	8.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—RAF1—dilated cardiomyopathy	1.97e-05	8.59e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.96e-05	8.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.91e-05	8.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD36—dilated cardiomyopathy	1.91e-05	8.34e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.91e-05	8.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.91e-05	8.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.91e-05	8.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—RAF1—dilated cardiomyopathy	1.91e-05	8.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—RAF1—dilated cardiomyopathy	1.91e-05	8.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.89e-05	8.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.89e-05	8.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.87e-05	8.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.87e-05	8.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.87e-05	8.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.86e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.85e-05	8.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.85e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.85e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD36—dilated cardiomyopathy	1.85e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD36—dilated cardiomyopathy	1.85e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.85e-05	8.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	8.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.82e-05	7.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.82e-05	7.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—RAC1—dilated cardiomyopathy	1.8e-05	7.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.8e-05	7.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.79e-05	7.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.79e-05	7.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.78e-05	7.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.77e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.77e-05	7.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—RAC1—dilated cardiomyopathy	1.74e-05	7.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—RAC1—dilated cardiomyopathy	1.74e-05	7.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.74e-05	7.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.74e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.73e-05	7.56e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	7.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.71e-05	7.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.68e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.66e-05	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—RAC1—dilated cardiomyopathy	1.66e-05	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	7.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.65e-05	7.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.62e-05	7.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—RAC1—dilated cardiomyopathy	1.61e-05	7.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—RAC1—dilated cardiomyopathy	1.61e-05	7.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.61e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.59e-05	6.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.58e-05	6.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.57e-05	6.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.55e-05	6.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.54e-05	6.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.53e-05	6.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.53e-05	6.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.52e-05	6.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—GPX1—dilated cardiomyopathy	1.52e-05	6.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.5e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.5e-05	6.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CD36—dilated cardiomyopathy	1.48e-05	6.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.48e-05	6.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—GPX1—dilated cardiomyopathy	1.47e-05	6.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—GPX1—dilated cardiomyopathy	1.47e-05	6.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.46e-05	6.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.45e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.45e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.44e-05	6.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.43e-05	6.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CD36—dilated cardiomyopathy	1.43e-05	6.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CD36—dilated cardiomyopathy	1.43e-05	6.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.41e-05	6.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EGFR—dilated cardiomyopathy	1.41e-05	6.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	5.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EGFR—dilated cardiomyopathy	1.36e-05	5.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EGFR—dilated cardiomyopathy	1.36e-05	5.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.35e-05	5.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	5.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.31e-05	5.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.31e-05	5.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.31e-05	5.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.31e-05	5.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.3e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.29e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AGT—dilated cardiomyopathy	1.29e-05	5.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AGT—dilated cardiomyopathy	1.29e-05	5.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	5.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.28e-05	5.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	5.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	5.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	5.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	5.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.24e-05	5.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.22e-05	5.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.21e-05	5.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—RAF1—dilated cardiomyopathy	1.2e-05	5.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.19e-05	5.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	5.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—RAF1—dilated cardiomyopathy	1.16e-05	5.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—RAF1—dilated cardiomyopathy	1.16e-05	5.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	4.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	4.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.12e-05	4.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.11e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—RAF1—dilated cardiomyopathy	1.1e-05	4.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	4.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—RAF1—dilated cardiomyopathy	1.07e-05	4.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—RAF1—dilated cardiomyopathy	1.07e-05	4.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.06e-05	4.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.04e-05	4.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.03e-05	4.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.83e-06	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.12e-06	3.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.97e-06	3.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.68e-06	3.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.68e-06	3.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	8.48e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.47e-06	3.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EGFR—dilated cardiomyopathy	8.2e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EGFR—dilated cardiomyopathy	7.93e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EGFR—dilated cardiomyopathy	7.93e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.73e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.66e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—dilated cardiomyopathy	7.57e-06	3.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.56e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.48e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.48e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—dilated cardiomyopathy	7.32e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—dilated cardiomyopathy	7.32e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	7.15e-06	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.09e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.04e-06	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.91e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.25e-06	2.72e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.22e-06	2.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.81e-06	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.3e-06	2.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.13e-06	2.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.13e-06	2.23e-05	CbGpPWpGaD
